Science & Tech
Is Biocon Fully Integrating Its Biologics Unit in a $5.5 Billion Deal?
Biocon is making a bold move to fully integrate its Biocon Biologics unit into a wholly owned subsidiary, valued at $5.5 billion. This strategic decision positions Biocon as a leader in the…